Repaglinide 0.5 mg Tablets
Last Updated on eMC 11-Jul-2016 View document | Actavis UK Ltd Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 11-Jul-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 10 - Date of revision of the text
Date of revision of text on the SPC: 20-Jun-2016
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Pharmacovigilance Risk Assessment Committee (PRAC) recommendations contained in the PSUR Assessment report resulting from the EU PSUSA (EMEA/H/C/PSUSA/00002618/201412) for repaglinide dated 10th September 2015.
SmPC sections updated – 4.5 and 10
Updated on 14-Jan-2014 and displayed until 11-Jul-2016
Reasons for adding or updating:
- Improved presentation of SPC
Date of revision of text on the SPC: 12-Apr-2013
Legal Category:POM
Black Triangle (CHM): NO
Updated on 02-Feb-2012 and displayed until 14-Jan-2014
Reasons for adding or updating:
- Change to section 6. 3 - Shelf Life
- Change to section 10 date of revision of the text
Date of revision of text on the SPC: 12-Jan-2012
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Section 6.3 has been updated to register a shelf life extension from 2 years to 3 years.Updated on 06-Jul-2011 and displayed until 02-Feb-2012
Reasons for adding or updating:
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
Date of revision of text on the SPC: 09-Jun-2011
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Add pack size of 180 tablets blister pack for finished product/UK SPC 6.5/PIL
Updated on 23-Jun-2011 and displayed until 06-Jul-2011
Reasons for adding or updating:
- New SPC for new product
Legal Category:POM
Black Triangle (CHM): NO
Actavis UK Ltd
Actavis UK Ltd, a subsidiary of Accord Healthcare Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
+44 (0)1271 346 106
+44 (0)1271 311 200
+44 (0)1271 385 257
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue